Proteasome degradation of brain cytosolic tau in Alzheimer's disease

International Journal of Clinical and Experimental Pathology

Volumn 4, Issue 4, 2011, Pages 385-402

  Yen, Samuel S ^a  

^a MAYO CLINIC   (United States)

Author keywords

Alzheimer's disease; Immunoblotting; Neurofibrillary; PHF tau; Proteasome; Size exclusion chromatography; Tau

Indexed keywords

PROTEASOME; PROTEIN SUBUNIT; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ARTICLE; BRAIN CORTEX; CASE CONTROL STUDY; CASE REPORT; CHEMISTRY; CYTOSOL; ENZYMOLOGY; FEMALE; GEL CHROMATOGRAPHY; HUMAN; MALE; METABOLISM; MIDDLE AGED; MOLECULAR WEIGHT; PATHOLOGY; PROTEIN PROCESSING; REGRESSION ANALYSIS; TEMPORAL LOBE; UNITED STATES; WESTERN BLOTTING;

AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CEREBRAL CORTEX; CHROMATOGRAPHY, GEL; CYTOSOL; FEMALE; FLORIDA; HUMANS; MALE; MIDDLE AGED; MINNESOTA; MOLECULAR WEIGHT; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN SUBUNITS; REGRESSION ANALYSIS; TAU PROTEINS; TEMPORAL LOBE;

EID: 80051605043     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Minati L, Edginton T, Bruzzone MG and Giaccone G. Current concepts in Alzheimer's disease: a multidisciplinary review. Am J Alzheimers Dis Other Demen 2009; 24: 95-121.
2. Lee VM, Balin BJ, Otvos L, Jr and Trojanowski JQ. A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science 1991; 251:675-678.
3. Grundke-Iqbal I, Iqbal K, Quinlan M, Wisniewski H and Binder L. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 1986; 261: 6084-6089.
4. Wischik CM, Novak M, Edwards PC, Klug A, Tichelaar W and Crowther RA. Structural characterization of the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci U S A 1988; 85: 4884-4888.
5. Selkoe DJ, Ihara Y and Salazar FJ. Alzheimer's disease: insolubility of partially purified paired helical filaments in sodium dodecyl sulfate and urea. Science 1982; 215:1243-1245.
6. Yen S S, Ishizawa T, Dickson D W, Boeve B, Knopman D, Smith G, Ivnik R, Peterson R, Lee G and Yen S-H. Correlation of tau and cognition in prospectively studied elderly humans. Neurobiol Aging 2002; 23: S490-491.
7. Goedert M, Wischik CM, Crowther RA, Walker JE and Klug A. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc Natl Acad Sci U S A 1988; 85: 4051-4055.
8. Jeganathan S, von Bergen M, Brutlach H, Steinhoff HJ and Mandelkow E. Global hairpin folding of tau in solution. Biochemistry 2006; 45: 2283-2293.
9. Brandt R, Leger J and Lee G. Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J Cell Biol 1995; 131:1327-1340.
10. Rendon A, Jung D and Jancsik V. Interaction of microtubules and microtubule-associated proteins (MAPs) with rat brain mitochondria. Biochem J 1990; 269: 555-556.
11. Loomis PA, Howard TH, Castleberry RP and Binder LI. Identification of nuclear tau isoforms in human neuroblastoma cells. Proc Natl Acad Sci U S A 1990; 87: 8422-8426.
12. David DC, Layfield R, Serpell L, Narain Y, Goedert M and Spillantini MG. Proteasomal degradation of tau protein. J Neurochem 2002; 83:176-185.
13. Kenessey A, Nacharaju P, Ko LW and Yen SH. Degradation of tau by lysosomal enzyme cathepsin D: implication for Alzheimer neurofibrillary degeneration. J Neurochem 1997; 69: 2026-2038.
14. Canu N, Dus L, Barbato C, Ciotto MT, Brancolini C, Rinaldi AM, Novak M, Cattaneo A, Bradbury A and Calissano P. Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis. J Neurosci 1998; 18: 7061-7074.
15. Yen SS, Easson C, Nacharaju P, Hutton M and Yen SH. FTDP-17 tau mutations decrease the susceptibility of tau to calpain I digestion. FEBS Lett 1999; 461: 91-95.
16. Carrard G, Bulteau AL, Petropoulos I and Friguet B. Impairment of proteasome structure and function in aging. Int J Biochem Cell Biol 2002; 34:1461-1474.
17. Baumeister W, Walz J, Zuhl F and Seemuller E. The proteasome: paradigm of a selfcompartmentalizing protease. Cell 1998; 92: 367-380.
18. Bochtler M, Ditzel L, Groll M, Hartmann C and Huber R. The proteasome. Annu Rev Biophys Biomol Struct 1999; 28: 295-317.
19. Coux O, Tanaka K and Goldberg AL. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 1996; 65: 801-847.
20. Groll M, Heinemeyer W, Jager S, Ullrich T, Bochtler M, Wolf DH and Huber R. The catalytic sites of 20S proteasomes and their role in subunit maturation: a mutational and crystallographic study. Proc Natl Acad Sci U S A 1999; 96:10976-10983.
21. Heinemeyer W, Fischer M, Krimmer T, Stachon U and Wolf DH. The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing. J Biol Chem 1997; 272: 25200-25209.
22. Heinemeyer W, Trondle N, Albrecht G and Wolf DH. PRE5 and PRE6, the last missing genes encoding 20S proteasome subunits from yeast? Indication for a set of 14 different subunits in the eukaryotic proteasome core. Biochemistry 1994; 33:12229-12237.
23. Jager S, Groll M, Huber R, Wolf DH and Heinemeyer W. Proteasome beta-type subunits: unequal roles of propeptides in core particle maturation and a hierarchy of active site function. J Mol Biol 1999; 291: 997-1013.
24. Kisselev AF, Akopian TN, Castillo V and Goldberg AL. Proteasome active sites allosterically regulate each other, suggesting a cyclical bitechew mechanism for protein breakdown. Mol Cell 1999; 4: 395-402.
25. Kisselev AF, Akopian TN, Woo KM and Goldberg AL The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation. J Biol Chem 1999; 274: 3363-3371.
26. Yewdell JW. Not such a dismal science: the economics of protein synthesis, folding, degradation and antigen processing. Trends Cell Biol 2001; 11: 294-297.
27. Wolf S, Nagy I, Lupas A, Pfeifer G, Cejka Z, Muller SA, Engel A, DeMot R and Baumeister W. Characterization of ARC, a divergent member of the AAA ATPase family from Rhodococcus erythropolis. J Mol Biol 1998; 277:13-25.
28. Bandyopadhyay B, Li G, Yin H and Kuret J. Tau aggregation and toxicity in a cell culture model of tauopathy. J Biol Chem 2007; 282: 16454-16464.
29. Crowe A, Ksiezak-Reding H, Liu WK, Dickson DW and Yen SH. The N terminal region of human tau is present in Alzheimer's disease protein A68 and is incorporated into paired helical filaments. Am J Pathol 1991; 139: 1463-1470.
30. Liu WK, Dickson DW and Yen SH. Heterogeneity of tau proteins in Alzheimer's disease. Evidence for increased expression of an isoform and preferential distribution of a phosphorylated isoform in neurites. Am J Pathol 1993; 142: 387-394.
31. Liu WK, Dickson DW and Yen SH. Amino acid residues 226-240 of tau, which encompass the first Lys-Ser-Pro site of tau, are partially phosphorylated in Alzheimer paired helical filamenttau. J Neurochem 1994; 62:1055-1061.
32. Liu WK, Moore WT, Williams RT, Hall FL and Yen SH. Application of synthetic phospho- and unphospho- peptides to identify phosphorylation sites in a subregion of the tau molecule, which is modified in Alzheimer's disease. J Neurosci Res 1993; 34: 371-376.
33. Ksiezak-Reding H, Chien CH, Lee VM and Yen SH. Mapping of the Alz 50 epitope in microtubule-associated proteins tau. J Neurosci Res 1990; 25: 412-419.
34. Peters JM, Franke WW and Kleinschmidt JA. Distinct 19 S and 20 S subcomplexes of the 26 S proteasome and their distribution in the nucleus and the cytoplasm. J Biol Chem 1994; 269: 7709-7718.
35. Dubiel W, Pratt G, Ferrell K and Rechsteiner M. Purification of an 11 S regulator of the multicatalytic protease. J Biol Chem 1992; 267: 22369-22377.
36. O'Brien MA, Moravec RA, Riss TL and Bulleit RF. Homogeneous, bioluminescent proteasome assays. Methods Mol Biol 2008; 414:163-181.
37. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993; 43: 2412-2414.
38. Kampers T, Friedhoff P, Biernat J, Mandelkow EM and Mandelkow E. RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments. FEBS Lett 1996; 399: 344-349.
39. Ksiezak-Reding H and Yen SH. Structural stability of paired helical filaments requires microtubule-binding domains of tau: a model for selfassociation. Neuron 1991; 6: 717-728.
40. Akopian TN, Kisselev AF and Goldberg AL. Processive degradation of proteins and other catalytic properties of the proteasome from Thermoplasma acidophilum. J Biol Chem 1997; 272:1791-1798.
41. Wenzel T and Baumeister W. Conformational constraints in protein degradation by the 20S proteasome. Nat Struct Biol 1995; 2: 199-204.
42. De Strooper B Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process. Physiol Rev 2010; 90: 465-494.
43. Ferreira ST, Vieira MN and De Felice FG. Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases. IUBMB Life 2007; 59: 332-345.
44. Tanahashi N, Murakami Y, Minami Y, Shimbara N, Hendil KB and Tanaka K. Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis. J Biol Chem 2000; 275: 14336-14345.